‘New vaccine needed’ as pertussis continues to evolve
Bacteria becoming a superbug, say researchers who have identified novel antigen agents
The need to develop new antigens to improve the pertussis vaccine is “pressing”, as the bacteria continues to evolve into a superbug, Sydney researchers warn.
In the latest in a series of studies, University of NSW microbiologist Dr Laurence Luu (PhD) and colleagues say they have identified novel antigens as potential vaccine targets.
